Understanding Schizophrenia: A Practical Guide for Patients, Families, and Health Care Professionalsby Ravinder Reddy, M.D., and Matcheri S. Keshavan, M.D.; Santa Barbara, California, Praeger, 2015, 212 pages.
Frese Frederick J
Psychiatric Services
2016
2016-05
Article information provided for research and reference use only. All rights are retained by the journal listed under publisher and/or the creator(s).
<a href="http://doi.org/10.1176/appi.ps.670603" target="_blank" rel="noreferrer noopener">10.1176/appi.ps.670603</a>
On the impact of being diagnosed with schizophrenia.
Adult; Humans; Male; Adaptation; Hospitalization; Schizophrenia; Stigma; Mental Health; Sick Role; *Mental Recall; Life Experiences; Antipsychotic Agents/adverse effects/therapeutic use; Delusions; Veterans/psychology; Vietnam Conflict; Psychological; Rehabilitation; Paranoid/*diagnosis/psychology/rehabilitation; Vocational/psychology; DIAGNOSIS of schizophrenia; FIRST person narrative; War; Military Personnel; Schizophrenia – Diagnosis
Frese Frederick J
Journal of mental health (Abingdon, England)
2010
2010-08
Article information provided for research and reference use only. All rights are retained by the journal listed under publisher and/or the creator(s).
<a href="http://doi.org/10.3109/09638237.2010.492419" target="_blank" rel="noreferrer noopener">10.3109/09638237.2010.492419</a>
Report on ISCTM Consensus Meeting on Clinical Assessment of Response to Treatment of Cognitive Impairment in Schizophrenia.
*Schizophrenic Psychology; Antipsychotic Agents/*therapeutic use; Cognition Disorders; Cognition Disorders/diagnosis/psychology/*therapy; cognitive assessment; Functional Assessment; Humans; Interviews; Neuropsychological Tests; neuropsychology; Nootropic Agents/*therapeutic use; Patient Selection; Psychiatric Rehabilitation/*methods; Research Instruments; Schizophrenia; Schizophrenia – Drug Therapy; Schizophrenia/diagnosis/*therapy; Severity of Illness Index; Surveys; treatment; United States Food and Drug Administration
If treatments for cognitive impairment are to be utilized successfully, clinicians must be able to determine whether they are effective and which patients should receive them. In order to develop consensus on these issues, the International Society for CNS Clinical Trials and Methodology (ISCTM) held a meeting of experts on March 20, 2014, in Washington, DC. Consensus was reached on several important issues. Cognitive impairment and functional disability were viewed as equally important treatment targets. The group supported the notion that sufficient data are not available to exclude patients from available treatments on the basis of age, severity of cognitive impairment, severity of positive symptoms, or the potential to benefit functionally from treatment. The group reached consensus that cognitive remediation is likely to provide substantial benefits in combination with procognitive medications, although a substantial minority believed that medications can be administered without nonpharmacological therapy. There was little consensus on the best methods for assessing cognitive change in clinical practice. Some participants supported the view that performance-based measures are essential for measurement of cognitive change; others pointed to their cost and time requirements as evidence of impracticality. Interview-based measures of cognitive and functional change were viewed as more practical, but lacking validity without informant involvement or frequent contact from clinicians. The lack of consensus on assessment methods was viewed as attributable to differences in experience and education among key stakeholders and significant gaps in available empirical data. Research on the reliability, validity, sensitivity, and practicality of competing methods will facilitate consensus.
Keefe Richard S E; Haig George M; Marder Stephen R; Harvey Philip D; Dunayevich Eduardo; Medalia Alice; Davidson Michael; Lombardo Ilise; Bowie Christopher R; Buchanan Robert W; Bugarski-Kirola Dragana; Carpenter William T; Csernansky John T; Dago Pedro L; Durand Dante M; Frese Frederick J; Goff Donald C; Gold James M; Hooker Christine I; Kopelowicz Alex; Loebel Antony; McGurk Susan R; Opler Lewis A; Pinkham Amy E; Stern Robert G
Schizophrenia bulletin
2016
2016-01
Article information provided for research and reference use only. All rights are retained by the journal listed under publisher and/or the creator(s).
<a href="http://doi.org/10.1093/schbul/sbv111" target="_blank" rel="noreferrer noopener">10.1093/schbul/sbv111</a>
State psychology licensure questions about mental illness and compliance with the Americans with Disabilities Act.
Disabled Persons/legislation & jurisprudence; Disclosure/*legislation & jurisprudence; Humans; Licensure/*legislation & jurisprudence; Mental Disorders/*psychology; Prejudice/legislation & jurisprudence; Psychology/*legislation & jurisprudence; United States
State licensing boards have obligations to protect the public from impaired professionals and to protect the rights of professionals applying for licensure. Competently functioning professionals who have or have had a mental health diagnosis or are being treated for a mental health condition should not be screened out, according to the Americans with Disabilities Act (ADA). A review of case law shows applicable precedents from discrimination among physicians and lawyers but not, to date, among psychologists. An examination of psychology licensure application materials from all 50 states and the District of Columbia revealed that some states, particularly Alaska, Arkansas, Colorado, Florida, Georgia, Kentucky, Missouri, Montana, and New Hampshire, include language that might screen out professionals with lived experience who are currently functioning competently. For comparison, we review a sample of licensure applications for physicians and lawyers and find a similar pattern. Five of the present authors offer ourselves and other published authors as examples of competent licensed psychologists who have lived with mental illnesses. We conclude with recommendations for more inclusive language and protection of confidentiality. (PsycINFO Database Record
Boyd Jennifer E; Graunke Bruce; Frese Frederick J; Jones James T R; Adkins Jennifer W; Bassman Ronald
The American journal of orthopsychiatry
2016
1905-07
Article information provided for research and reference use only. All rights are retained by the journal listed under publisher and/or the creator(s).
<a href="http://doi.org/10.1037/ort0000177" target="_blank" rel="noreferrer noopener">10.1037/ort0000177</a>